StemRIM Inc. announced that extension the collaborative research period of the tripartite joint research agreement, updated on January 24, 2023, with Shiseido Co. Ltd. and Osaka University. Collaborative research, conducted among company, Shiseido, and Osaka University, focuses on elucidating the aging mechanisms of skin stem cells with a particular emphasis on anti-aging of the skin.

The aim is to create new pharmaceuticals, cosmetics, and related products based on data obtained from understanding the aging mechanisms. Through the ongoing collaborative research, the company have achieved certain research results regarding changes in stem cells related to skin aging. Recognizing the need for further analysis, the company have extended the research period to continue advancing research towards the creation of new pharmaceuticals and cosmetics.